Published in Acta Biomater on March 13, 2014
In vivo monitoring of Staphylococcus aureus biofilm infections and antimicrobial therapy by [18F]fluoro-deoxyglucose-MicroPET in a mouse model. Antimicrob Agents Chemother (2014) 0.80
Scaffold-based anti-infection strategies in bone repair. Ann Biomed Eng (2014) 0.75
Bacterial biofilms: a common cause of persistent infections. Science (1999) 40.82
Prosthetic-joint infections. N Engl J Med (2004) 12.71
Points of control in inflammation. Nature (2002) 10.61
Treatment of infections associated with surgical implants. N Engl J Med (2004) 8.49
Surface protein adhesins of Staphylococcus aureus. Trends Microbiol (1998) 6.86
Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol (2001) 4.18
Near-infrared fluorescence: application to in vivo molecular imaging. Curr Opin Chem Biol (2009) 2.89
Identification of plasma proteins adsorbed on hemodialysis tubing that promote Staphylococcus aureus adhesion. J Lab Clin Med (2000) 2.06
Optical imaging of bacterial infection in living mice using a fluorescent near-infrared molecular probe. J Am Chem Soc (2006) 1.93
In vivo bioluminescence imaging for integrated studies of infection. Cell Microbiol (2004) 1.89
Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog (2010) 1.88
Applying insights from biofilm biology to drug development - can a new approach be developed? Nat Rev Drug Discov (2013) 1.82
Protein A-mediated multicellular behavior in Staphylococcus aureus. J Bacteriol (2008) 1.81
Medical biofilms. Biotechnol Bioeng (2008) 1.70
Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil. Proc Natl Acad Sci U S A (2005) 1.65
New approaches for treating staphylococcal biofilm infections. Ann N Y Acad Sci (2011) 1.56
Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection. Antimicrob Agents Chemother (2003) 1.56
Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice. Proc Natl Acad Sci U S A (2010) 1.51
Photodynamic therapy for Acinetobacter baumannii burn infections in mice. Antimicrob Agents Chemother (2009) 1.50
Noninvasive optical imaging of staphylococcus aureus bacterial infection in living mice using a Bis-dipicolylamine-Zinc(II) affinity group conjugated to a near-infrared fluorophore. Bioconjug Chem (2008) 1.34
Maltodextrin-based imaging probes detect bacteria in vivo with high sensitivity and specificity. Nat Mater (2011) 1.30
Refining animal models in fracture research: seeking consensus in optimising both animal welfare and scientific validity for appropriate biomedical use. BMC Musculoskelet Disord (2007) 1.20
Far-red light photoactivatable near-infrared fluorescent proteins engineered from a bacterial phytochrome. Nat Commun (2013) 1.18
Bioluminescence imaging: looking beyond the light. Trends Mol Med (2012) 1.12
Towards the identification of the common features of bacterial biofilm development. Int Microbiol (2006) 1.01
Deep-red fluorescent imaging probe for bacteria. Bioorg Med Chem Lett (2012) 0.96
Improved lux reporters for use in Staphylococcus aureus. Plasmid (2009) 0.94
Bacterial luciferase reporters: the Swiss army knife of molecular biology. Bioeng Bugs (2011) 0.93
Minimally invasive, longitudinal monitoring of biomaterial-associated inflammation by fluorescence imaging. Biomaterials (2011) 0.93
Role of plasma and extracellular matrix proteins in the physiopathology of foreign body infections. Ann Vasc Surg (1998) 0.91
Disruption of β-oxidation pathway in Pseudomonas putida KT2442 to produce new functionalized PHAs with thioester groups. Appl Microbiol Biotechnol (2011) 0.87
Efficient recovery of low endotoxin medium-chain-length poly([R]-3-hydroxyalkanoate) from bacterial biomass. J Microbiol Methods (2007) 0.83
PHACOS, a functionalized bacterial polyester with bactericidal activity against methicillin-resistant Staphylococcus aureus. Biomaterials (2013) 0.81